Clinical trial
A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-Traumatic Stress Disorder (PTSD)
NCT02479906 is registered in ClinicalTrials.gov with Brainsway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-Traumatic Stress Disorder (PTSD)
- Lead sponsor
- Brainsway
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 17, 2016
- Completion date
- March 31, 2020
- Enrollment
- 203 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
post-traumatic stress disorder